会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 33. 发明授权
    • Process for producing biphenylpolycarboxylic acid ester
    • 联苯多羧酸酯的制备方法
    • US3983159A
    • 1976-09-28
    • US498182
    • 1974-08-16
    • Yataro IchikawaTeizo Yamaji
    • Yataro IchikawaTeizo Yamaji
    • C07C67/00C07C69/76
    • C07C67/00C07C69/76
    • The oxidative coupling of benzenecarboxylic acid esters to form the corresponding biphenylpolycarboxylic acid esters, comprising contacting a benzenecarboxylic acid ester having at least one hydrogen atom bonded to the nuclear carbon atom of the benzene ring, such as methyl benzeate, with molecular oxygen in a liquid phase using a catalyst comprising at least one compound selected from organic carboxylates of palladium, such as palladium acetate and .beta.-dikete complexes of palladium, such as acetylacetone-palladium complex. Use of at least one zirconium compound, such as zirconium oxystearate in conjunction with the catalyst gives rise to an increased catalytic activity.
    • 苯甲酸酯的氧化偶合形成相应的联苯多羧酸酯,包括将具有至少一个与苯环的核碳原子键合的氢原子的苯甲酸酯如苯甲酸甲酯与液相中的分子氧接触 使用包含至少一种选自钯的有机羧酸盐,例如乙酸钯和钯的β-二乙基络合物如乙酰丙酮 - 钯络合物的化合物的催化剂。 使用至少一种锆化合物,例如氧化钼硬脂酸锆与催化剂结合产生增加的催化活性。
    • 34. 发明授权
    • Process for the preparation of unsaturated carbonyl compounds
    • 不饱和羰基化合物的制备方法
    • US3978092A
    • 1976-08-31
    • US467618
    • 1974-05-06
    • Yataro IchikawaMamoru Yamamoto
    • Yataro IchikawaMamoru Yamamoto
    • C07C45/51C07C47/21C07D307/42C07D307/46C07C47/20C07C47/45
    • C07D307/42C07C45/513C07C45/515C07C47/21C07D307/46
    • An unsaturated carbonyl compound, for example, one expressed by the following formula ##EQU1## is prepared by maintaining at an elevated temperature an allyl acetal of an .alpha.,.beta.-unsaturated aldehyde, for example, one expressed by the following formula ##EQU2## or a novel dienyl ether derived from it, for example, one expressed by the following formula ##EQU3## The allyl acetal can be derived, for example, from .beta.-methylcrotonaldehyde having 5 carbon atoms and prenyl alcohol having 5 carbon atoms. It is possible therefore to introduce an allyl residue containing at least 3 carbon atoms into the carbon atoms at the .gamma.-position to the carbonyl group of an .alpha., .beta.-unsaturated aldehyde containing at least 5 carbon atoms by a reaction consisting of the reduced number of steps. Moreover, the unsaturated aldehyde having the increased number of carbon atoms can be formed at a high yield by a relatively simple reaction.
    • 通过保持在升高的温度下制备不饱和羰基化合物,例如由下式表示的CH 3 CH 3 | H3C-C = CH-CH 2 -CH 2 -C = CH-CHO的一种不饱和羰基化合物,其中α,β-不饱和的烯丙基缩醛 醛,例如,由下式表示的CH 3 CH 3 || CH 2 -CH = C-CH 3 H3C-C = CH-CH 2 O-CH 2 -CH = C-CH 3 | CH 3或新型二烯基醚衍生物 例如,由下式表示的CH 3 CH 3 || CH 2 = C-CH = CH-O-CH 2 -CH = C-CH 3所示的烯丙基缩醛可以衍生自例如具有5碳的β-甲基巴豆醛 具有5个碳原子的原子和异戊醇。 因此,可以通过由减少的数目组成的反应将含有至少3个碳原子的烯丙基残基引入到含有至少5个碳原子的α,β-不饱和醛的γ-位上的碳原子 的步骤。 此外,可以通过相对简单的反应以高产率形成碳原子数增加的不饱和醛。
    • 38. 依法登记的发明
    • Method of separating activated human protein C
    • USH1148H
    • 1993-03-02
    • US815870
    • 1992-01-03
    • Kenji WakabayashiYoshihiko SumiYataro IchikawaYoichi SakataNobuo Aoki
    • Kenji WakabayashiYoshihiko SumiYataro IchikawaYoichi SakataNobuo Aoki
    • C07K16/40C12N9/64
    • C12N9/6464C07K16/40C12Y304/21069
    • A method of separating activated human protein C, which comprises bringing a mixture containing activated human protein C having a gamma-carboxyglutamic acid (Gla) domain in the presence of a calcium ion into contact with a fixed antibody comprising an insoluble carrier and fixed thereto an antibody to a complex of human protein C and a calcium ion bound to the Gla domain whereby the activated human protein C is captured by the fixed antibody in the form in which the calcium ion is bound to the Gla domain. A method is also provided for separating activated human protein C from a mixture containing human protein C and activated human protein C, which comprises bringing a first mixture containing human protein C and activated human protein C having a Gla domain into contact with a first fixed antibody comprising an insoluble carrier and fixed thereto a first antibody to human protein C but not to activated human protein C to form a second mixture substantially free from human protein C while the human protein C is captured by the first fixed antibody, and bringing the second mixture in the presence of a calcium ion into contact with a second fixed antibody comprising an insoluble carrier and fixed thereto a second antibody to a complex of human protein C and a calcium ion bound at the Gla domain, whereby the activated human protein C is captured by the second fixed antibody in the form in which the calcium ion is bound to the Gla domain.
    • 39. 发明授权
    • Immunological determination of free human protein S and C4bp-protein S
complex
    • 游离人蛋白S和C4bp蛋白S复合物的免疫测定
    • US5187067A
    • 1993-02-16
    • US670383
    • 1991-03-14
    • Yukiya KoikeKenji WakabayashiYoshihiko SumiYataro Ichikawa
    • Yukiya KoikeKenji WakabayashiYoshihiko SumiYataro Ichikawa
    • C07K16/18C07K16/36C12N5/18
    • C07K16/18C07K16/36Y10S436/821Y10S436/824
    • A method of immunologically determining free human protein S in an assay sample, which comprises contacting a primary antibody fixed to an insoluble solid carrier and a labelled secondary antibody with the assay sample, the primary and secondary antibodies having the property of binding to different epitopes of free human protein S, and one of the primary and secondary antibodies being a monoclonal antibody having the property of not binding to a complex of the human protein S and human complement cofactor C4b-binding protein (C4bp) but specifically binding to the free human protein S. Also provided is a method of immunologically determining a complex of human protein S and human complement cofactor C4b-binding protein (C4bp) in an assay sample, which comprises contacting a primary antibody fixed to an insoluble solid carrier and a labelled secondary antibody with the assay sample, one of the primary and secondary antibodies being a monoclonal antibody having the property of not binding to free human protein S and human complement cofactor C4b-binding protein (C4bp) but binding specifically to the complex, and the other being an antibody having the property of binding to the human complement cofactor C4b-binding protein (4Cbp).
    • 一种在测定样品中免疫测定游离人蛋白S的方法,其包括将固定在不溶性固体载体上的第一抗体与标记的第二抗体与测定样品接触,所述第一抗体和第二抗体具有结合不同表位的性质 游离人蛋白S,其中一种和第二种抗体是具有不与人类蛋白S和人补体辅因子C4b结合蛋白(C4bp)的复合物结合但与结合游离人蛋白质的特异性的单克隆抗体 还提供了在测定样品中免疫测定人蛋白S和人补体辅因子C4b结合蛋白(C4bp)的复合物的方法,其包括将固定于不溶性固体载体的第一抗体和标记的第二抗体与 测定样品,其中一种和第二种抗体是具有不结合特性的单克隆抗体 g释放人蛋白S和人补体辅因子C4b结合蛋白(C4bp),但与复合物特异性结合,另一种是具有与人补体辅因子C4b结合蛋白(4Cbp)结合的性质的抗体。